Publicerad: 2021-11-17 13:09 | Uppdaterad: 2021-11-17 13:34

Aktuella utlysningar, vecka 46, 2021

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

Project grants: Applied Welfare Research 2022 – the Swedish Research Council for Health, Working Life and Welfare (FORTE)

The national programme on applied welfare research welcomes proposals within eight priority areas. The programme aims to strengthen long-term knowledge expansion and development within the social services, and to strengthen collaboration between research and practice. In total, around SEK 40 million is reserved for the period 2022-2025. The grants are approved for a minimum of two years and a maximum of four years.

Closing date: 14 December 2021

Further information

Working groups within the EU Joint Programme – Neurodegenerative Disease Research (JPND)

JPND initiative has launched a call for expert working groups on the impact of Covid-19 on neurodegenerative disease research. One grant type is available within this call: working groups. The Working Groups will be funded for up to 9 months with 50.000 EURO. The grant will not fund direct research activities instead it will fund working groups and cover their expenses (e.g., meetings and travel costs). The working groups must provide outputs of value to the broader research community, such as best-practice guidelines and methodological frameworks.

Focus of the research: The COVID-19 pandemic has had a major impact on almost all aspects of our life and will most likely result in major long-lasting changes in the future. These changes include how research on neurodegenerative disease is conducted during and after the pandemic. Patients suffering from neurodegenerative disease are among the most vulnerable to COVID-19 infections and the measures of social distancing and quarantine. To address this challenge, JPND will launch a call for scientists in the field to establish Working Groups dedicated to discuss research strategies that concern the impact of COVID-19 on the development and progression of neurodegenerative disease as well as on the care of persons with neurodegenerative diseases.

For Forte to approve Swedish applicants, the applicant must have completed a doctoral degree.

Closing date: 14 December 2021

Further information

Research grants and scholarships – Konsul Th C Bergh Foundation

These support research conducted in Sweden in the field of allergies. A special grant worth SEK 100,000 is awarded to researchers who have defended their dissertations in 2020 or 2021.

Closing date: 16 December 2021

Further information

Junior Investigator Award for projects at Karolinska Institutet aimed at achieving the UN sustainable development goals.

The UN has developed 17 Sustainable Development Goals (SDG) to be achieved by 2030, representing some of the biggest challenges the world is facing today. KI is devoted to finding solutions to health challenges and to help fulfil these goals as described in Strategy 2030: A deep global, national, and local commitment to human health shall characterize our education and research.

KI intents to fund about five projects with a budget of 100 000 - 300 000 SEK per project, including departmental INDI, for a period of one year (total budget for the call is 1.000.000 SEK). At least one of the five projects shall be linked to SDG 13 Climate action to aid the fulfillment of the goals in our climate strategy.

The main applicant must have completed the doctoral degree after 1 January 2014 (or after 1 January 2012 in case of parental leave) and latest before the application deadline, and, must be employed at KI, or affiliated to KI. The project must be new and should be relevant to several SDGs.

Closing date: 18 January 2022

Further information

Grants – Swedish Childhood Cancer Foundation (Barncancerfonden)

Grants for symposia and work meetings

These support the organisation of one to two day research symposia within the area of children oncology. Grants are worth up to SEK 500,000 each.

Guest lecturer

This funds visits by prominent international guest lecturers in the field of paediatric oncology. The grant is worth up to SEK 20,000.

PhD courses

This supports organising PhD courses within the field of paediatric oncology. The grants fully or partially cover venue costs, the lecturer’s fee, and course material.

Closing date: 17 January 2022

Further information

Forskningsstöd – Dr Per Håkanssons Stiftelse

Forskningsstöd ges till disputerade forskare i tidig karriär som enligt Stiftelsens regler måste vara verksamma med inriktning mot livsmedel och hälsa. I förekommande fall kan stödet helt eller delvis ges som postdoktoralt utbildningsstipendium med bidrag till kostnader för värdinstitutionen. Etablerade forskare (exempelvis innehavare av tjänster som professor, universitetslektor, forskare vid vetenskapligt råd) prioriteras inte i jämförelse med icke-etablerade forskare. Forskningsstöden ges företrädesvis till forskare, som redovisar forskningsprojekt som bedöms vara av betydelse för de stora folksjukdomarna. Högst prioritet ges för projekt inom områden där kosten/födan är av betydelse för prevention och/eller behandling. Varje anslag/stipendium har tidigare år legat mellan 300.000-600.000 kronor. Projekt kan rekommenderas för tvååriga anslag.

Closing date: 28 February 2022

Further information

Europeiska utlysningar

International grants - Biocodex Microbiota Foundation, FR

The Biocodex Microbiota Foundation invites applications for its international grants. These support clinical or fundamental research projects focused on human gut microbiota related to health and disease. For the current round, projects will explore the functional role of antibiotic resistance genes within the gut microbiome, with a focus on anaerobic microorganisms that are difficult to assess in routine clinical microbiology

Physicians, PhDs and doctors of pharmacy working in subject areas, such as gastroenterology, paediatrics, microbiology, infectious diseases and internal medicine and based anywhere in the world, may apply. Researchers must be affiliated with universities, hospitals or other research settings.

The grant is worth €200,000 over one to three years.

Closing date: 30 November 2021

Further information

National grant – Nordic and Baltic countries - Biocodex Microbiota Foundation

The Biocodex Microbiota Foundation invites applications for its national grant – Nordic and Baltic countries. This supports scientific research initiatives involving the human gut microbiota in human health and diseases.

Research must be carried out in an institution in Nordic-Baltic countries. Postdoctoral investigators are encouraged to apply. Grants will be awarded to the selected research institutions in Nordic-Baltic countries.

Grants are worth between €10,000 and €20,000 depending on which country the applicant is from.

Closing date: 31 December 2021

Further information

Projects in paediatric cancer - European Science Foundation, EU

The European Science Foundation, under its Fight Kids Cancer programme and in partnership with Imagine for Margo, the Fondatioun Kriibskrank Kanner and the Italian Federation of Parents and Patients of Paediatric Oncology, invites applications for its projects in paediatric cancer. These support the development of better targeted and less toxic therapies for paediatric cancer.

The lead applicant must be based in any of the following countries: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK. Other project partners are encouraged but must be non-profits entities. Applicants must have experience working in paediatric cancer.

The total budget is €4 million. Grants are worth up to €500,000 each for translational research projects or up to €1.5m each for early-phase clinical trials.

Closing date: 30 November 2021

Further information

ASCAPE open call - ASCAPE, EUR

ASCAPE invites applications for its open call. This supports healthcare institutes, companies or research teams in evaluating the efficacy and applicability of ASCAPE’s solution and artificial intelligence models achieving broader participation and involvement in the ASCAPE framework development. Funding is available under the following sub-calls:

•evaluation of ASCAPE open AI infrastructure in healthcare institutions;

•contribute to new algorithms to improve or train ASCAPE open AI infrastructure to detect new types of cancer or medical conditions.

Applicants must be based in the EU or H2020 associated countries.

The budget is €250,000 and three to five grants are available. Grants are worth up to €40,000 each.

Closing date: 10 December 2021

Further information

Italian Fund for Science – fundamental research call - Ministry of Universities and Research

The Ministry of Universities and Research, under its Italian Fund for Science (FIS), invites applications for its fundamental research call. This supports fundamental research in the sciences in Italy. The following grants are available:

•starting grants, for applicants who are between two and 10 years from receiving their PhD – the total budget is €20 million to fund grants worth up to €1m each;

•advanced grants, for applicants who are more than 10 years from receiving their PhD – the total budget is €30m to fund grants worth up to €1.5m each.

Applicants may be of any nationality. They must demonstrate research expertise, with a minimum number of peer-reviewed publications and international recognition. The grant must be held at an Italian university or public research institution and applicants must enter into an employment agreement with the host institution at least for the duration of the grant. Applications must be submitted in English.

The maximum project period is five years. Projects in the life sciences, physical sciences or engineering may request up to an additional €500,000 for the purchase of equipment.

Closing date: 27 December 2021

Further information

Clinical research training fellowship – postdoctoral call - Medical Research Council, GB

The Medical Research Council invites applications for its clinical research training fellowship – postdoctoral call. This enables postdoctoral applicants who achieved their PhD some time ago to reacquire research skills. Applications are welcome across all areas of the MRC’s remit, ranging from basic studies to translational and developmental clinical research.

Postdoctoral applicants must be clinically qualified and have received their PhD five or more years ago and have not undertaken substantial periods of academic research since.

Fellowships are for a period of two to three years, or four years for patient-oriented clinical research. At the postdoctoral level, the fellowship covers salary up to but not including NHS consultant level, research expenses and travel costs under full economic costs.

Closing date:12 January 2022

COMING SOONER THAN YOU THINK: ERC-2022-AdG Advanced Grants -- Horizon Europe: Excellent Science, EU and other funders

These support established, leading principal investigators who want long-term funding to pursue a ground-breaking, high-risk project. Applicants should be exceptional leaders in terms of originality and significance of their research contributions, with a track record of significant research achievements in the last ten years.  Applications may be made in any field of research, with an emphasis on the frontiers of science, scholarship, and engineering.

Advanced Grants may be awarded up to €2.5 million for a period of 5 years, though an additional € 1 million can be made available under certain circumstances.

If you are interested in applying for an ERC Advanced Grant with KI as host institution, please contact KI Grants Office for further information.

Closing date: 28 April 2022

Further information

Amerikanska utlysningar

Federal Funding agencies

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional), NIH

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative approaches to identifying, understanding, and developing strategies for overcoming barriers to the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions, tools, policies, and guidelines. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (“de-implement”) the use of interventions that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. All applications must be within scope of the mission of one of the Institutes/Centers listed above. This FOA uses the R21 mechanism. The R21 activity code is intended to encourage new exploratory and developmental research projects.

Closing date: Standard dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-275

Further information

Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional), NIH

The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice. Specifically, the focus of this FOA is on the identification and initial biological, analytical and clinical evaluation of biomarkers and biomarker signatures for neurological and neuromuscular disorders/diseases. Although research supported by this FOA can include animal studies, it must also include preliminary human evaluation using carefully standardized human samples or datasets. The goal of this initiative is to deliver candidate biomarkers or biomarker signatures that are ready for definitive analytical and clinical validation studies.

Closing date: February 22, 2022 by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-315

Further information

Telomeres in Wellness and Disease: A Biobehavioral Approach  (R01, R21 Clinical Trial Optional), NIH

The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that examines the role of telomeres in wellness and disease, and to advance the incorporation of telomere studies into biobehavioral programs of research. A body of research has demonstrated the contribution of telomeres to health-related outcomes; however, additional studies are needed to achieve the full potential for incorporating telomere-guided approaches for maintaining wellness, reducing the risk and burden of disease, and for advancing symptom and self-management strategies.

Closing date: Standard dates apply. All applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PA-19-074 (R01), PA-19-073 (R21)

Further information (R01)

Further information (R21)